Currently out of the existing stock ratings of Travis Steed, 46 are a HOLD (29.87%), 96 are a BUY (62.34%), 12 are a SELL (7.79%).

Travis Steed

Work Performance Price Targets & Ratings Chart

Analyst Travis Steed, currently employed at BAML, carries an average stock price target met ratio of 59.2% that have a potential upside of 19.42% achieved within 239 days.

Travis Steed’s has documented 307 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Financial Services, Communication Services sectors.

Most recent stock forecast was given on BDX, Becton Dickinson and Company at 31-Aug-2026.

Wall Street Analyst Travis Steed

Analyst best performing recommendations are on LUNG (PULMONX CORP).
The best stock recommendation documented was for LUNG (PULMONX CORP) at 1/3/2023. The price target of $8 was fulfilled within 1 day with a profit of $0.51 (6.81%) receiving and performance score of 68.09.

Average potential price target upside

ABT Abbott Laboratories AXNX Axonics Modulation Technologies DXCM DexCom INMD InMode Ltd ZBH Zimmer Biomet Holdings BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp EW Edwards Lifesciences Corp ISRG Intuitive Surgical MDT Medtronic PLC PODD Insulet SYK Stryker TNDM Tandem Diabetes Care CNMD CONMED LUNG Pulmonx Corp SWAV Shockwave Medical WMGI Wright Medical Group N.V INSP Inspire Medical Systems NARI Inari Medical SILK Silk Road Medical AXGN Axogen OM Outset Medical SOLV Solventum Corp. IART Integra LifeSciences Holdings EMBC Embecta Corp PEN Penumbra AX Axos Financial CSII Cardiovascular Systems WMG Warner Music Group MASI Masimo

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Dec-2018

$120

$20.4 (20.48%)

$143

Buy Since 23-Jan-2017

$135

$35.4 (35.54%)

$135

1 months 3 days ago
(08-Sep-2026)

26/39 (66.67%)

$29.48 (27.94%)

336

Hold Since 13-Aug-2026

$130

$30.4 (30.52%)

1 months 28 days ago
(13-Aug-2026)

2/3 (66.67%)

$18.73 (16.83%)

29

Buy Since 28-Jul-2026

$125

$25.4 (25.50%)

$117

2 months 13 days ago
(28-Jul-2026)

4/5 (80%)

$17.73 (16.53%)

116

Buy Since 06-Jun-2019

$112

$12.4 (12.45%)

$108

2 months 24 days ago
(17-Jul-2026)

25/32 (78.13%)

$11.32 (11.24%)

420

Show more analysts

Please expand the browser size to see the chart

Which stock is Travis Steed most bullish on?

Potential upside of $91.04 has been obtained for ISRG (INTUITIVE SURGICAL)

Which stock is Travis Steed most reserved on?

Potential downside of -$4.42 has been obtained for CNMD (CONMED)

What Year was the first public recommendation made by Travis Steed?

On 2015
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?